Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 20, 1985 - Issue 8
Submit an article Journal homepage
21
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Liver Disease in α1-Antitrypsin Deficiency: Aspects of Incidence and Prognosis

Sten G. Eriksson Dept. of Medicine, Malmö General Hospital University of Lund, S-214 01, Malmö, Sweden
Pages 907-911 | Published online: 08 Jul 2009

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ronald D. Feld. (1989) Heterozygosity of α1-Antitrypsin: A Health Risk?. Critical Reviews in Clinical Laboratory Sciences 27:6, pages 461-481.
Read now

Articles from other publishers (29)

Shen Li, Antonio Saviano, Derek J. Erstad, Yujin Hoshida, Bryan C. Fuchs, Thomas Baumert & Kenneth K. Tanabe. (2020) Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges. Journal of Clinical Medicine 9:12, pages 3817.
Crossref
Junjiang Pan, Ding Cao & Jianping Gong. (2018) The endoplasmic reticulum co-chaperone ERdj3/DNAJB11 promotes hepatocellular carcinoma progression through suppressing AATZ degradation. Future Oncology 14:29, pages 3001-3013.
Crossref
A.P. Lopes, M.A. Mineiro, F. Costa, J. Gomes, C. Santos, C. Antunes, D. Maia, R. Melo, M. Canotilho, E. Magalhães, I. Vicente, C. Valente, B.G. Gonçalves, B. Conde, C. Guimarães, C. Sousa, J. Amado, M.E. Brandão, M. Sucena, M.J. Oliveira, S. Seixas, V. Teixeira & L. Telo. (2018) Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 24, pages 1-21.
Crossref
Nunzia Pastore, Sergio Attanasio, Barbara Granese, Raffaele Castello, Jeffrey Teckman, Andrew A. Wilson, Andrea Ballabio & Nicola Brunetti‐Pierri. (2017) Activation of the c‐Jun N‐terminal kinase pathway aggravates proteotoxicity of hepatic mutant Z alpha1‐antitrypsin. Hepatology 65:6, pages 1865-1874.
Crossref
Clara Antoury. (2015) Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease. World Journal of Hepatology 7:10, pages 1427.
Crossref
Pauline Levinson, Hans Glaumann & Märten Söderberg. (2013) Probable Dalteparin‐Induced Hepatotoxicity in a Man With Alpha‐1‐Antitrypsin Deficiency. The Journal of Clinical Pharmacology 52:11, pages 1764-1767.
Crossref
David R. Nelson, Jeffrey Teckman, Adrian M. Di Bisceglie & David A. Brenner. (2012) Diagnosis and Management of Patients With α1-Antitrypsin (A1AT) Deficiency. Clinical Gastroenterology and Hepatology 10:6, pages 575-580.
Crossref
Nancy Y. Marcus, Elizabeth M. Brunt, Keith Blomenkamp, Faiza Ali, David A. Rudnick, Muneeb Ahmad & Jeffrey H. Teckman. (2010) Characteristics of hepatocellular carcinoma in a murine model of alpha‐1‐antitrypsin deficiency. Hepatology Research 40:6, pages 641-653.
Crossref
P. Spagnolo, S. Zeuzem, L. Richeldi & R. M. Du Bois. (2010) The complex interrelationships between chronic lung and liver disease: a review. Journal of Viral Hepatitis 17:6, pages 381-390.
Crossref
O SummN GregorM MarziniakI GralowIW HusstedtS Evers. (2009) Cluster Headache and Alpha 1-antitrypsin Deficiency. Cephalalgia 30:1, pages 113-117.
Crossref
Edwin K. Silverman & Robert A. Sandhaus. (2009) Alpha 1 -Antitrypsin Deficiency . New England Journal of Medicine 360:26, pages 2749-2757.
Crossref
Hui Zhou & Hans-Peter Fischer. (1998) Liver Carcinoma in PiZ Alpha-1-Antitrypsin Deficiency. The American Journal of Surgical Pathology 22:6, pages 742-748.
Crossref
Guido Massi. (1996) Pathogenesis and Pathology of Liver Disease Associated With α1-Antitrypsin Deficiency. Chest 110:6, pages 251S-255S.
Crossref
D. J. F. Feist. 1995. Inborn Metabolic Diseases. Inborn Metabolic Diseases 361 363 .
JR Poley. (1994) Malignant liver disease in alpha 1 -antitrypsin deficiency . Acta Paediatrica 83:s393, pages 27-32.
Crossref
Klaus Pittschieler. (1994) Heterozygotes and liver involvement. Acta Paediatrica 83:s393, pages 21-23.
Crossref
Barry A. Hicks & R. Peter Altman. (1993) The Jaundiced Newborn. Pediatric Clinics of North America 40:6, pages 1161-1175.
Crossref
KLAUS PITTSCHIELER. (2008) Liver Disease and Heterozygous Alpha‐1‐Antitrypsin Deficiency. Acta Paediatrica 80:3, pages 323-327.
Crossref
Eduardo Ibarguen, Cynthia R. Gross, S. Kay Savik & Harvey L. Sharp. (1990) Liver disease in alpha-1-antitrypsin deficiency: Prognostic indicators. The Journal of Pediatrics 117:6, pages 864-870.
Crossref
D. C. S. Hutchison. (1990) The epidemiology ofα 1-antitrypsin deficiency. Lung 168:S1, pages 535-542.
Crossref
Jacques Van Dam & Jerome B. Zeldis. (1990) Hepatic Diseases in the Elderly. Gastroenterology Clinics of North America 19:2, pages 459-472.
Crossref
Dimitrios Trichopoulos, Anastasia Tzonou, Victoria Kalapothaki, Loucas Sparos, Tzenny Kremastinou & Maria Skoutari. (1990) Alpha1-antitrypsin and survival in pancreatic cancer. International Journal of Cancer 45:4, pages 685-686.
Crossref
D. Feist. 1990. Inborn Metabolic Diseases. Inborn Metabolic Diseases 565 568 .
D T Curiel, M D Holmes, H Okayama, M L Brantly, C Vogelmeier, W D Travis, L E Stier, W H Perks & R G Crystal. (1989) Molecular Basis of the Liver and Lung Disease Associated with the α1-Antitrypsin Deficiency Allele Mmalton. Journal of Biological Chemistry 264:23, pages 13938-13945.
Crossref
Duncan C.S. Hutchison. (1988) Natural history of alpha-1-protease inhibitor deficiency. The American Journal of Medicine 84, pages 3-12.
Crossref
Duncan C.S. Hutchison. (1988) Natural history of alpha-1-protease inhibitor deficiency. The American Journal of Medicine 84:6, pages 3-12.
Crossref
Joseph F. Fitzgerald. (1988) Cholestatic Disorders of Infancy. Pediatric Clinics of North America 35:2, pages 357-373.
Crossref
Jorge Rakela, Markus Goldschmiedt & Jurgen Ludwig. (1987) Late manifestation of chronic liver disease in adults with alpha-1-antitrypsin deficiency. Digestive Diseases and Sciences 32:12, pages 1358-1362.
Crossref
Cynthia L. Reid, Gregory J. Wiener, Diane W. Cox, Joel E. Richter & Kim R. Geisinger. (1987) Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of α1-antitrypsin. Gastroenterology 93:1, pages 181-187.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.